OneMedNet Corporation (ONMD)
OneMedNet Statistics
Share Statistics
OneMedNet has 27.99M shares outstanding. The number of shares has increased by 17.35% in one year.
Shares Outstanding | 27.99M |
Shares Change (YoY) | 17.35% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 15.89M |
Failed to Deliver (FTD) Shares | 1.95K |
FTD / Avg. Volume | 2.66% |
Short Selling Information
The latest short interest is 71.45K, so 0.26% of the outstanding shares have been sold short.
Short Interest | 71.45K |
Short % of Shares Out | 0.26% |
Short % of Float | 0.45% |
Short Ratio (days to cover) | 1.46 |
Valuation Ratios
The PE ratio is -0.25 and the forward PE ratio is null. OneMedNet's PEG ratio is 0.
PE Ratio | -0.25 |
Forward PE | n/a |
PS Ratio | 5.62 |
Forward PS | null |
PB Ratio | -0.43 |
P/FCF Ratio | -1.19 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for OneMedNet.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03, with a Debt / Equity ratio of -0.38.
Current Ratio | 0.03 |
Quick Ratio | 0.03 |
Debt / Equity | -0.38 |
Debt / EBITDA | -0.23 |
Debt / FCF | -1.05 |
Interest Coverage | -11.18 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $51.08K |
Profits Per Employee | $-1.16M |
Employee Count | 20 |
Asset Turnover | 2.2 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -21.71% in the last 52 weeks. The beta is 0.72, so OneMedNet's price volatility has been higher than the market average.
Beta | 0.72 |
52-Week Price Change | -21.71% |
50-Day Moving Average | 0.75 |
200-Day Moving Average | 0.91 |
Relative Strength Index (RSI) | 36.57 |
Average Volume (20 Days) | 73.22K |
Income Statement
In the last 12 months, OneMedNet had revenue of 1.02M and earned -23.21M in profits. Earnings per share was -4.77.
Revenue | 1.02M |
Gross Profit | -127.9K |
Operating Income | -8.37M |
Net Income | -23.21M |
EBITDA | -22.43M |
EBIT | -22.46M |
Earnings Per Share (EPS) | -4.77 |
Balance Sheet
The company has 47K in cash and 5.09M in debt, giving a net cash position of -5.05M.
Cash & Cash Equivalents | 47K |
Total Debt | 5.09M |
Net Cash | -5.05M |
Retained Earnings | -91.44M |
Total Assets | 4.39M |
Working Capital | -14.32M |
Cash Flow
In the last 12 months, operating cash flow was -4.79M and capital expenditures -44K, giving a free cash flow of -4.83M.
Operating Cash Flow | -4.79M |
Capital Expenditures | -44K |
Free Cash Flow | -4.83M |
FCF Per Share | -0.68 |
Margins
Gross margin is -12.52%, with operating and profit margins of -819.68% and -2271.37%.
Gross Margin | -12.52% |
Operating Margin | -819.68% |
Pretax Margin | -2271.37% |
Profit Margin | -2271.37% |
EBITDA Margin | -2195.3% |
EBIT Margin | -819.68% |
FCF Margin | -473.25% |
Dividends & Yields
ONMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ONMD.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -54.21 |
Piotroski F-Score | 5 |